Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen
Nava Siegelmann-Danieli, Daniel Kurnik, Yossi Lomnicky, Janet Vesterman-Landes, Itzhak Katzir, Martin Bialik, Ronen LoebsteinVolume:
125
Language:
english
Pages:
6
DOI:
10.1007/s10549-010-1008-7
Date:
January, 2011
File:
PDF, 170 KB
english, 2011